Guardant Health, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending June 30, 2025: -49.43%

Guardant Health, Inc. EBIT Margin is -49.43% for the Trailing 12 Months (TTM) ending June 30, 2025, a -34.75% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.
  • Guardant Health, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending June 30, 2024 was -75.75%, a -23.35% change year over year.
  • Guardant Health, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending June 30, 2023 was -98.83%, a -23.81% change year over year.
  • Guardant Health, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending June 30, 2022 was -129.71%, a 15.62% change year over year.
  • Guardant Health, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending June 30, 2021 was -112.19%, a 147.44% change year over year.
Key Data
Date EBIT Margin EBITDA Margin Net Income Margin EBT Margin